PIRAMAL PHARMA
Back to Income Statement
|
PIRAMAL PHARMA Last 5 Year Consolidated Net Profit History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Consolidated Net Profit | ₹-326 Cr | ₹91 Cr | ₹18 Cr | ₹-186 Cr | ₹376 Cr |
What is the latest Consolidated Net Profit of PIRAMAL PHARMA ?
| Year | Consolidated Net Profit |
|---|---|
| Mar2026 | ₹-326 Cr |
| Mar2025 | ₹91 Cr |
| Mar2024 | ₹18 Cr |
| Mar2023 | ₹-186 Cr |
| Mar2022 | ₹376 Cr |
How is Consolidated Net Profit of PIRAMAL PHARMA Trending?
| Years | Consolidated Net Profit | % Change | |
|---|---|---|---|
| Mar2026 | ₹-326 Cr | Negative | |
| Mar2025 | ₹91 Cr | 411.39 | |
| Mar2024 | ₹18 Cr | Positive | |
| Mar2023 | ₹-186 Cr | Negative | |
| Mar2022 | ₹376 Cr | - | |
Compare Consolidated Net Profit of peers of PIRAMAL PHARMA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| PIRAMAL PHARMA | ₹25,747.3 Cr | 9.2% | 16.1% | -9.3% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹474,396.0 Cr | 1.8% | 5.6% | 16.7% | Stock Analytics | |
| DIVIS LABORATORIES | ₹196,990.0 Cr | 0.5% | 13.1% | 10.9% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹186,354.0 Cr | -2.7% | 5.1% | 42.4% | Stock Analytics | |
| CIPLA | ₹116,705.0 Cr | 2.1% | -0.6% | -4.5% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹94,790.0 Cr | -4% | -17.5% | -8.6% | Stock Analytics | |
PIRAMAL PHARMA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| PIRAMAL PHARMA | 9.2% |
16.1% |
-9.3% |
| SENSEX | -0.9% |
-0.4% |
-6.1% |
You may also like the below Video Courses